o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate has been researched along with mipafox in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casida, JE; Li, W | 1 |
| Fink, JK; Hein, ND; Rainier, SR; Richardson, RJ; Stuckey, JA | 1 |
| Del Río, E; Estévez, J; Fuster, E; Sogorb, MA; Vilanova, E | 1 |
3 other study(ies) available for o,o-diethyl o-3,5,6-trichloro-2-pyridyl phosphate and mipafox
| Article | Year |
|---|---|
Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells.
Topics: Acetylcholinesterase; Animals; Carboxylic Ester Hydrolases; Cell Differentiation; Cell Survival; Chlorpyrifos; Cholinesterase Inhibitors; Enzyme Inhibitors; Isoflurophate; Neurites; Organophosphorus Compounds; Sensitivity and Specificity; Tritolyl Phosphates; Tumor Cells, Cultured | 1998 |
Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.
Topics: Carboxylic Ester Hydrolases; Catalytic Domain; Chlorpyrifos; Enzyme Inhibitors; Humans; Hydrolysis; Isoflurophate; Kinetics; Motor Neuron Disease; Mutagenesis, Site-Directed; Mutation; Recombinant Proteins; Spastic Paraplegia, Hereditary; Substrate Specificity; Valerates | 2010 |
Effects of mipafox, paraoxon, chlorpyrifos and its metabolite chlorpyrifos-oxon on the expression of biomarker genes of differentiation in D3 mouse embryonic stem cells.
Topics: Animals; Biomarkers; Carboxylic Ester Hydrolases; Cell Differentiation; Cell Survival; Chlorpyrifos; Gene Expression Regulation, Developmental; Gene Silencing; Isoflurophate; Mice; Mouse Embryonic Stem Cells; Paraoxon | 2016 |